Assessing the role of lncrna slamr in the pathogenesis of alzheimers disease
Active Grant Awarded
- Award ID
- R21AG094050
- Recipient
-
University Of Florida UEI NNFQH1JAPEP3
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $507,214
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 40% complete
- Place of performance
- Jupiter, FL 33458, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded Grant R21AG094050 to the University of Florida Division of Sponsored Research on February 6, 2026, with $507,214 obligated under Assistance Listing 93.866, Aging Research. The exploratory/developmental R21 award funds a systematic investigation of how the long noncoding RNA SLAMR regulates expression and function in Alzheimer's disease pathogenesis. Planned work includes assessing SLAMR-mediated translation in the APP NL-G-F knock-in mouse model and the PS19 tau model of Alzheimer's disease. The award's ultimate completion date is January 31, 2028, and its place of performance is Jupiter, FL 33458, USA.
The Winifred Masterson Burke Medical Research Institute, Inc. received a sub-award dated March 9, 2026 (R21AG094050-SUB00005194). Its described work is oversight of the electrophysiology, behavior, and immunohistochemistry aims by Dr. Syed Abid Hussaini, who discusses results weekly with the postdoc, reports results to Dr. Puthanveettil, and prepares yearly RPPR reports.
The program supports biomedical, social, and behavioral research and training on aging, with the National Institute on Aging emphasizing prevention and treatment of Alzheimer's disease and related dementias.
Description
- Abstract
- The functions of long-noncoding rnas (LNCRNAS) as crucial regulators of transcription, epigenetic modifications, mrna stability, localization, and translation indicate their potential involvement in alzheimer's disease (ad) pathogenesis. Given the impairment of these fundamental cellular processes in ad, LNCRNAS emerge as plausible targets. Consistent with this possibility, several studies have demonstrated altered expression of specific LNCRNAS in various ad models. However, the precise roles, mechanisms, and cell-specific contributions of these LNCRNAS in ad development remain unclear. This exploratory/developmental R21 proposal aims to systematically investigate the regulation of expression and function of lncrna slamr in the pathogenesis of ad. Slamr lncrna was discovered from an unbiased screen of learning regulated LNCRNAS. We find that slamr lncrna in mouse CA1 is critical for synapse density, morphology, plasticity and memory. Importantly, we find that slamr functions as a key modulator of translation and structural plasticity. Gain of function of slamr resulted in enhanced translation and functional synapses. Our preliminary data show that slamr expression is impaired in APP knock-in (APP NL-G-F) mouse model of ad. We will now assess the role of slamr mediated translation in APP NL-G-F model and TAU model (PS19) of ad. Our systematic functional experiments are anticipated to unveil the role of slamr in the progression of ad pathogenesis. Successful completion of this proposal will shed light on the significance of LNCRNAS in ad pathogenesis and influence the development of lncrna-based therapeutics for ad.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Winifred Masterson Burke Medical Research Institute, Inc. | $71,227 |
Quick answers
Who received award R21AG094050?
R21AG094050 was awarded to University Of Florida by National Institute on Aging (National Institutes of Health) on February 6, 2026.
How much is award R21AG094050 worth?
$507,214 has been obligated on R21AG094050.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award